Rationale and design of a randomized, double-blind, placebo-controlled trial of 6 versus 12 months clopidogrel therapy after implantation of a drug-eluting stent: The Intracoronary Stenting and Antithrombotic Regimen: Safety And EFficacy of 6 Months Dual Antiplatelet Therapy After Drug-Eluting Stenting (ISAR-SAFE) study-Reference-Cited by-同舟云学术

Rationale and design of a randomized, double-blind, placebo-controlled trial of 6 versus 12 months clopidogrel therapy after implantation of a drug-eluting stent: The Intracoronary Stenting and Antithrombotic Regimen: Safety And EFficacy of 6 Months Dual Antiplatelet Therapy After Drug-Eluting Stenting (ISAR-SAFE) study

Published:2009-04 Issue:4 Volume:157 Page:620-624.e2
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Byrne Robert A.,Schulz Stefanie,Mehilli Julinda,Iijima Raisuke,Massberg Steffen,Neumann Franz-Josef,ten Berg Jurriёn M.,Schömig Albert,Kastrati Adnan

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference33 articles.

1. Stent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concern;Camenzind;Circulation,2007

2. Duration of Antiplatelet Therapy Following Intracoronary Stenting: Are Changes Needed?;Byrne;Eur Heart J Suppl,2008

3. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents;Schomig;N Engl J Med,1996

4. A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators;Leon;N Engl J Med,1998

5. Double-Blind Study of the Safety of Clopidogrel With and Without a Loading Dose in Combination With Aspirin Compared With Ticlopidine in Combination With Aspirin After Coronary Stenting

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Complexity of Antiplatelet Therapy in Coronary Artery Disease Patients;American Journal of Cardiovascular Drugs;2020-05-12

2. Management of anticoagulation and antiplatelet therapy in patients with primary membranous nephropathy;BMC Nephrology;2019-12

3. Is there an optimal duration of Dual Antiplatelet Therapy after Drug-Eluting Stent Implantation?;EMJ Interventional Cardiology;2017-07-04

4. Comparison of Baseline Characteristics and Inhospital Outcomes of Patients and Use of Bare Metal Versus Drug-Eluting Stents During Percutaneous Coronary Intervention 2005 to 2015 at a Single Tertiary Hospital;The American Journal of Cardiology;2017-05

5. Balancing the risk of spontaneous ischemic and major bleeding events in acute coronary syndromes;American Heart Journal;2017-04